Overview

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Investigators propose to develop hyperpolarized [13C]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Neurotransmitter Agents